Three quarters of a mile from civilization
Views, analysis & commentary - essentially on venture capital & pharmaceutical industry
Showing posts with label
Attrition
.
Show all posts
Showing posts with label
Attrition
.
Show all posts
Thursday, January 24, 2013
The clinical attrition of INX-189 post a 2.5 billion acquisition - are investors into life sciences really looking at where the buck is headed?
›
October 2012 Discussion initiated on Global Private Equity & Venture Capital group on Linkedin http://www.linkedin.com/groupItem?vi...
1 comment:
INX-189 clinical attrition - a call for re-look at single isomer strategy of Gilead?
›
October 2012 Discussion posted Pharmaceutical Discussion Group on LinkedIn http://www.linkedin.com/groups/INX-189-clinical-attrition...
›
Home
View web version